Tokyo Tape
Sign in
← MedPeer

Quarterly report · Q2

6095.TEDINET S100TEBI
Period2023-10-01 → 2024-03-31
Filed2024-05-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥7.9bn2023-10-01 → 2024-03-31Cons.Net sales
Revenue¥14.5bn2022-10-01 → 2023-09-30Cons.Net sales (5-year summary)
Revenue¥7.1bn2022-10-01 → 2023-03-31Cons.Net sales
Operating income¥836m2023-10-01 → 2024-03-31Cons.Operating income
Operating income¥717m2022-10-01 → 2023-03-31Cons.Operating income
Ordinary income¥831m2023-10-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥1.2bn2022-10-01 → 2023-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥735m2022-10-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥550m2023-10-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥735m2022-10-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥199m2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥618m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥380m2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥213m2023-10-01 → 2024-03-31Cons.Profit loss
Net income¥391m2022-10-01 → 2023-03-31Cons.Profit loss
Total assets¥14.9bnat 2024-03-31Cons.Assets
Total assets¥15.2bnat 2023-09-30Cons.Assets
Total assets¥14.5bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥6.2bnat 2024-03-31Cons.Liabilities
Total liabilities¥6.6bnat 2023-09-30Cons.Liabilities
Net assets / equity¥8.7bnat 2024-03-31Cons.Net assets
Net assets / equity¥8.6bnat 2023-09-30Cons.Net assets
Net assets / equity¥8.6bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥5.8bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥5.4bnat 2023-09-30Cons.Cash and deposits
Cash & equivalents¥5.8bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥5.7bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥6.1bnat 2022-09-30dCons.Cash and cash equivalents
Operating cash flow¥807m2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥600m2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥122m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥47m2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥5.0bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.8bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥378m2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥3.7bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥9.182023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-4.162024-01-01 → 2024-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.332022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥17.422022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.032023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥27.992022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥17.052022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio56.5%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio57.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-03-31−¥434,000
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-03-31−¥434,000
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31−¥685m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥6.4bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥6.4bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥15,000
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2023-10-01 → 2024-03-31¥1.5bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥234m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥234m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2023-10-01 → 2024-03-31−¥131m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2023-10-01 → 2024-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2023-10-01 → 2024-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥419,000
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2023-10-01 → 2024-03-31¥153m
—segment totalrevenue2023-10-01 → 2024-03-31¥7.9bn
—segment totalrevenue external2023-10-01 → 2024-03-31¥7.9bn
—segment totalrevenue intersegment2023-10-01 → 2024-03-31¥434,000
—segment totalsegment profit2023-10-01 → 2024-03-31¥1.5bn
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31−¥657m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥2m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥1.3bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥243m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥240m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥3m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2022-10-01 → 2023-03-31−¥40m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥300,000
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥94m
—segment totalrevenue2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue external2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue intersegment2022-10-01 → 2023-03-31¥5m
—segment totalsegment profit2022-10-01 → 2023-03-31¥1.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 519
ItemContextValueUnit
Subtotal ope cfPrior1YTDDuration347677000JPY
Subtotal ope cfCurrentYTDDuration1045955000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration699000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration675000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-7117000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-6331000JPY
Income taxes paid ope cfPrior1YTDDuration-218948000JPY
Income taxes paid ope cfCurrentYTDDuration-233607000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration122311000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration806693000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-3840000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-19652000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-28432000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-32218000JPY
Purchase of investment securities inv cfPrior1YTDDuration-120508000JPY
Purchase of investment securities inv cfCurrentYTDDuration-525000JPY
Proceeds from collection of lease and guarantee deposits inv cfPrior1YTDDuration79000JPY
Proceeds from collection of lease and guarantee deposits inv cfCurrentYTDDuration－JPY
Collection of loans receivable inv cfPrior1YTDDuration1015000JPY
Collection of loans receivable inv cfCurrentYTDDuration900000JPY
Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YTDDuration-4648102000JPY
Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfCurrentYTDDuration－JPY
Other net inv cfPrior1YTDDuration3062000JPY
Other net inv cfCurrentYTDDuration4083000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-4796727000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-47413000JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration4200000000JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration－JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-293300000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-280151000JPY
Proceeds from issuance of common stock fin cfPrior1YTDDuration338015000JPY
Proceeds from issuance of common stock fin cfCurrentYTDDuration－JPY
Cash dividends paid fin cfPrior1YTDDuration－JPY
Cash dividends paid fin cfCurrentYTDDuration-97351000JPY
Purchase of treasury stock fin cfPrior1YTDDuration-66000JPY
Purchase of treasury stock fin cfCurrentYTDDuration－JPY
Other net fin cfPrior1YTDDuration-875000JPY
Other net fin cfCurrentYTDDuration-892000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration4243773000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-378394000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration-430642000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration380885000JPY
Cash and cash equivalentsPrior2YearInstant6138758000JPY
Cash and cash equivalentsPrior1YearInstant5393167000JPY
Cash and cash equivalentsPrior1QuarterInstant5708116000JPY
Cash and cash equivalentsCurrentQuarterInstant5774053000JPY
Directors compensations sgaPrior1YTDDuration146720000JPY
Directors compensations sgaCurrentYTDDuration147350000JPY
Compensations salaries and allowances sgaPrior1YTDDuration873284000JPY
Compensations salaries and allowances sgaCurrentYTDDuration909285000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-09-30pass
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass